Almazov Centre is carrying out clinical trials of the Tianox nitric oxide device.
The device was developed by Sarov scientists from the Russian Federal Nuclear Centre – All-Russia Research Institute of Experimental Physics (a ROSATOM’s company) and is intended for the production of nitric oxide from atmospheric air and inhaled nitric oxide therapy for various diseases in children and adults.
Modern medicine is increasingly using the achievements of biotechnology and cell biology to achieve not only longer life expectancy, but also a better quality of life. However, there is a long way to go from the success of fundamental science, in particular, experimental oncology and oncoimmunology, to clinical practice. Many Russian families faced with a terrible diagnosis of cancer refuse to perceive it as a death sentence and are looking for accessible research advancements, modern high-quality care and treatment.
Continue reading »
The Anesthesiology and Intensive Care Unit of Polenov Neurosurgical Institute was established in the 60s of the last century. The work of this department is based on the fundamental achievements of neurophysiology. Proprietary methods of anesthetic management, neuromonitoring, brain protection against ischemia/hypoxia have been patented and derived from the current understanding of passive-defensive reactions and sanogenesis mechanisms in severe multiple pathological effects on the brain. Ekaterina Kondratieva, neurologist, leading researcher of the Anesthesiology and Intensive Care Unit, tells more about this.
Continue reading »
The surgeons of Almazov Centre performed a rare surgery in a young man to implant a new-generation domestic ventricular assist device designed for long-term mechanical support of the left ventricle.
A 35-year-old man from Kaliningrad was admitted to Almazov Centre in October 2018 with decompensated chronic heart failure on the background of dilated cardiomyopathy – the impaired contractile function of the heart muscle (myocardium) with marked dilatation of heart chambers. According to statistics, only 30% of patients with this disease survive the first five years…
A research team from ITMO University and Almazov Centre proposed a new non-contact method for measuring blood flow in the upper limbs. The method is based on video recording of the skin surface under green light measuring the absorption of red blood cells. This helps see how effective the circulatory system and the blood flow regulation are. The experimental results showed that the proposed method is as accurate as the traditional one. However, it is easier to use, cheaper and suitable for more patients. The research was published in Biomedical Optics Express.
Lower limb varicose vein disease is a major problem in healthcare worldwide. About 25% of the Russian population suffers from various forms of varicose vein disease, and its prevalence and frequency continue to grow. Having a progressive irreversible course, the disease leads to various manifestations of chronic venous insufficiency, including non-healing venous ulcers and venous thromboembolism. In order to prevent the development of such serious complications, patients are encouraged to start treatment as soon as possible.
Continue reading »
Nowadays, 3D technologies have been increasingly used in many fields of medicine. Tests have already been done to produce bone cartilage for the kneecap, nose and ears. Also, scientists are working to make 3D-bioprinted artificial eyeballs. This is difficult, but if successful, it will become possible to restore vision to blind people. All evidence suggests, that soon 3D bioprinters will be capable of printing whole cells from human organ stem cells.
Continue reading »
The idea of using immunity mechanisms to fight malignant diseases has been around for more than a hundred years now. It has long been known that there are special cells in the human body – T lymphocytes, NK cells and macrophages – which are able to recognize and destroy pathologically altered tumor cells.
Continue reading »
In April, 2017, the vascular surgeons under the supervision of the Head of the Vascular and Interventional Surgery Department, Dr. Mikhail Chernyavsky, performed endoprosthesis replacement of aorta in two patients. One of them had a giant aneurysm of the abdominal aorta of 10 cm in size, while the other had an aneurysm of a complicated topographic anatomy in the form of an hourglass extending to the iliac arteries.
Continue reading »
Today, one of priorities for Almazov Centre is the work on personalized and translational medicine in the Centre, in St. Petersburg and in Russia. Translational medicine is a fast transfer of basic research results (mainly in the field of cell and molecular biology and biochemistry) into clinical practice, i.e. the creation of diagnostic protocol or therapeutic treatment target based on the identified molecular-cellular mechanisms of disease pathogenesis. The aim of personalized medicine is to create diagnostic algorithms and treatment strategy taking into account patient’s individual (genetic) characteristics. Today, these types of clinical practice include molecular diagnostics and pharmacogenetics.
УВАЖАЕМЫЕ ПОСЕТИТЕЛИ ЦЕНТРА АЛМАЗОВА!
Уведомляем вас, что в соответствии с Федеральным законом от 06.03.2006 № 35-ФЗ «О противодействии терроризму» в Центре Алмазова введен комплекс дополнительных мер по безопасности, направленный на предотвращение террористических актов. В целях обеспечения безопасности граждан и целостности объектов инфраструктуры при посещении Центра Алмазова проводится дополнительный личный осмотр, осмотр вещей и автотранспорта. Отказ от соблюдения мер по безопасности может послужить причиной недопуска на территорию Центра Алмазова. Просим с пониманием отнестись к введенным мерам по безопасности.
С уважением, Администрация Центра Алмазова
